Clinical Trials Logo

Paranoid Schizophrenia clinical trials

View clinical trials related to Paranoid Schizophrenia.

Filter by:
  • None
  • Page 1

NCT ID: NCT04902066 Active, not recruiting - Psychotic Disorders Clinical Trials

Face Your Fears: Cognitive Behavioural Virtual Reality Therapy for "Paranoia".

FYF
Start date: April 9, 2021
Phase: N/A
Study type: Interventional

The study is a randomised, assessor-blinded parallel-groups superiority clinical trial fulfilling the CONSORT criteria for non-pharmacological treatment. A total of 256 patients will be allocated to either Cognitive Behavioural Virtual Reality Therapy plus treatment as usual, versus traditional CBT for psychosis plus treatment as usual. All participants will be assessed at baseline and 3- and 9 months post baseline. A stratified block-randomisation with concealed randomisation sequence will be conducted. Independent assessors blinded to the treatment will evaluate outcome. Analysis of outcome will be carried out with the intention to treat principles.

NCT ID: NCT00506077 Completed - Clinical trials for Paranoid Schizophrenia

MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016)

Start date: December 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the safety and effectiveness of an investigational drug MK0249 for the treatment of the cognitive impairment in patients with schizophrenia.

NCT ID: NCT00482430 Completed - Schizophrenia Clinical Trials

MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)

Start date: September 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the safety and effectiveness of an investigational drug for the treatment of cognitive impairment in patients with schizophrenia.